Study | Study qualitya | Effect statistic (95% CI) | Descriptor of magnitude | Level of evidence b |
---|---|---|---|---|
Pain | ||||
 VAS and NPRS | ||||
  6–8 weeks | ||||
   Aasa et al. 2015 [30] | Good | − 0.13 [− 0.60, 0.34] | Trivial | Moderate |
   Atalay et al. 2017 [36] | Fair | − 0.33 [− 1.21, 0.56] | Small | |
   Cai et al. 2015 [31] | Good | − 0.30 [− 0.85, 0.25] | Small | |
   Suh et al. 2019 [35] | Good | − 0.50 [− 1.34, 0.34] | Moderate | |
   Overall 6–8 weeks |  | − 0.26 [− 0.56, 0.05] | Small |  |
  12–16 weeks | ||||
   Cortell-Tormo et al. 2018 [14] | Good | − 0.83 [− 1.67, 0.01] | Large | Strong |
   Hurley et al. 2015 [32] | Good | 0.17 [− 0.16, 0.50] | Small | |
   Jackson et al. 2011 [MA] [33] | Good | − 0.92 [− 1.68, − 0.16] | Large | |
   Jackson et al. 2011 [OA] [33] | Good | − 0.91 [− 1.67, − 0.15] | Large | |
   Kell et al. 2009 [34] | Good | − 0.87 [− 1.85, 0.10] | Large | |
   Overall 12–16 weeks |  | − 0.61 [− 1.21, 0.00] | Moderate |  |
   Overall pain |  | − 0.41 [− 0.72, − 0.10] | Small | Strong |
Disability | ||||
 ODI and PSFS | ||||
  6–8 weeks | ||||
   Aasa et al. 2015 [30] | Good | − 0.38 [− 0.85, 0.09] | Small | Moderate |
   Atalay et al. 2017 [36] | Fair | − 0.22 [− 1.10, 0.66] | Small | |
   Cai et al. 2015 [31] | Good | 0.15 [− 0.40, 0.70] | Trivial | |
   Suh et al. 2019 [35] | Good | − 0.05 [− 0.88, 0.77] | Trivial | |
   Overall 6–8 weeks |  | − 0.15 [− 0.46, 0.16] | Trivial |  |
  12–16 weeks | ||||
   Cortell-Tormo et al. 2018 [14] | Good | − 0.91 [− 1.76, − 0.06] | Large | Strong |
   Hurley et al. 2015 [32] | Good | − 0.02 [− 0.35, 0.31] | Trivial | |
   Jackson et al. 2011 [MA] [33] | Good | − 0.74 [− 1.49, 0.00] | Moderate | |
   Jackson et al. 2011 [OA] [33] | Good | − 0.75 [− 1.49, − 0.00] | Moderate | |
   Kell et al. 2009 [34] | Good | − 0.75 [− 1.72, 0.21] | Moderate | |
   Overall 12–16 weeks |  | − 0.53 [− 0.97, − 0.09] | Moderate |  |
   Overall LOD |  | − 0.31 [− 0.56, − 0.06] | Small | Strong |
Strength | ||||
   6–8 weeks | ||||
   Aasa et al. 2015 [30] | Good | 0.19 [− 0.28, 0.66] | Trivial | Conflicting |
   Atalay et al. 2017 [36] | Fair | 0.41 [− 0.48, 1.30] | Small | |
   Cai et al. 2015 [31] | Good | 0.51 [− 0.04, 1.07] | Moderate | |
   Overall 6–8 weeks |  | 0.34 [0.00, 0.67] | Small |  |
  12–16 weeks | ||||
   Jackson et al. 2011 [MA] [33] | Good | 0.67 [− 0.07, 1.41] | Moderate | Strong |
   Jackson et al. 2011 [OA] [33] | Good | 0.67 [− 0.07, 1.40] | Moderate | |
   Kell et al. 2009 [34] | Good | 0.68 [− 0.28, 1.64] | Moderate | |
   Overall 12–16 weeks |  | 0.67 [0.21, 1.13] | Moderate |  |
   Overall strength |  | 0.45 [0.18, 0.72] | Small | Strong |